in a double-blind comparative study , the therapeutic efficacy and safety of three centrally effective antispasmodics ( tetrazepam , baclofen and tizanidine ) in patients suffering from multiple sclerosis with spastic motor disturbances of the lower extremities was to be examined .
C0004609
baclofen
C0026769
multiple sclerosis